Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tolamolol

Known as: 4-(2-(2-hydroxy-3-o-tolyloxypropylamino)ethoxy)benzamide, totamidol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
The chiral resolution of some clinically used drugs namely metoprolol, teratolol, tolamolol, nebivolol (beta-adrenergic blockers… Expand
Highly Cited
1980
Highly Cited
1980
The effects of five beta-adrenoreceptor blocking agents and placebo during twice daily sustained therapy were compared in 23… Expand
1979
1979
Abstract 1 Four groups of patients with previously untreated essential hypertension in WHO stage I were treated either with… Expand
Highly Cited
1979
Highly Cited
1979
We compared the immediate effects of five beta-adrenoreceptor-blocking agents in 16 patients with stable angina pectoris. Acute… Expand
1977
1977
1 Twelve men with untreated essential hypertension in WHO stage I were studied on an outpatient basis to evaluate the… Expand
Highly Cited
1976
Highly Cited
1976
  • H. H. Harms
  • The Journal of pharmacology and experimental…
  • 1976
  • Corpus ID: 26398029
pA2 values against isoproterenol were determined for a number of cardioselective and noncardioselective beta adrenergic receptor… Expand
1975
1975
Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg… Expand
1975
1975
The electrophysiologic effects of tolamolol (UK-6558-01), a beta-adrenergic blocking agent, were studied in 13 patients by means… Expand
1974
1974
Abstract Tolamolol was found to be a potent, competitive β-adrenoceptor blocking agent in vitro and in vivo using tissues of the… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
1973
1973
Orally administered tolamolol, a new cardioselective beta-adrenergic blocking drug, was evaluated in 30 patients with… Expand